595 related articles for article (PubMed ID: 32452979)
1. Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab.
Dolinger MT; Person H; Smith R; Jarchin L; Pittman N; Dubinsky MC; Lai J
J Pediatr Gastroenterol Nutr; 2020 Aug; 71(2):153-155. PubMed ID: 32452979
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?
Bardasi G; Alvisi P
Dig Liver Dis; 2020 Nov; 52(11):1244-1245. PubMed ID: 32703727
[No Abstract] [Full Text] [Related]
3. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
Pereira MFB; Litvinov N; Farhat SCL; Eisencraft AP; Gibelli MABC; Carvalho WB; Fernandes VR; Fink TT; Framil JVS; Galleti KV; Fante AL; Fonseca MFM; Watanabe A; Paula CSY; Palandri GG; Leal GN; Diniz MFR; Pinho JRR; Silva CA; Marques HHS; ; Rossi Junior A; Delgado AF; Andrade APM; Schvartsman C; Sabino EC; Rocha MC; Kanunfre KA; Okay TS; Carneiro-Sampaio MMS; Jorge PPD
Clinics (Sao Paulo); 2020; 75():e2209. PubMed ID: 32844958
[TBL] [Abstract][Full Text] [Related]
4. Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.
Duret PM; Sebbag E; Mallick A; Gravier S; Spielmann L; Messer L
Ann Rheum Dis; 2020 Sep; 79(9):1251-1252. PubMed ID: 32354772
[No Abstract] [Full Text] [Related]
5. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Soy M; Keser G; Atagündüz P; Tabak F; Atagündüz I; Kayhan S
Clin Rheumatol; 2020 Jul; 39(7):2085-2094. PubMed ID: 32474885
[TBL] [Abstract][Full Text] [Related]
6. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
[TBL] [Abstract][Full Text] [Related]
7. Is it all MIS-C? Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children after SARS-CoV-2 infection.
Mehler K; Jung N; Oberthuer A
Int J Infect Dis; 2021 May; 106():405-408. PubMed ID: 33864915
[TBL] [Abstract][Full Text] [Related]
8. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report.
Kofman AD; Sizemore EK; Detelich JF; Albrecht B; Piantadosi AL
BMC Infect Dis; 2020 Sep; 20(1):716. PubMed ID: 32993540
[TBL] [Abstract][Full Text] [Related]
9. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
Diorio C; Henrickson SE; Vella LA; McNerney KO; Chase J; Burudpakdee C; Lee JH; Jasen C; Balamuth F; Barrett DM; Banwell BL; Bernt KM; Blatz AM; Chiotos K; Fisher BT; Fitzgerald JC; Gerber JS; Gollomp K; Gray C; Grupp SA; Harris RM; Kilbaugh TJ; John ARO; Lambert M; Liebling EJ; Paessler ME; Petrosa W; Phillips C; Reilly AF; Romberg ND; Seif A; Sesok-Pizzini DA; Sullivan KE; Vardaro J; Behrens EM; Teachey DT; Bassiri H
J Clin Invest; 2020 Nov; 130(11):5967-5975. PubMed ID: 32730233
[TBL] [Abstract][Full Text] [Related]
10. Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.
Bahrami M; Kamalinejad M; Latifi SA; Seif F; Dadmehr M
Phytother Res; 2020 Oct; 34(10):2429-2430. PubMed ID: 32472655
[TBL] [Abstract][Full Text] [Related]
11. TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis.
Chen XY; Yan BX; Man XY
Ther Adv Respir Dis; 2020; 14():1753466620926800. PubMed ID: 32436460
[TBL] [Abstract][Full Text] [Related]
12. Targeting the NLRP3 Inflammasome in Severe COVID-19.
Freeman TL; Swartz TH
Front Immunol; 2020; 11():1518. PubMed ID: 32655582
[TBL] [Abstract][Full Text] [Related]
13. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
[No Abstract] [Full Text] [Related]
14. Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children.
Cron RQ
Curr Opin Rheumatol; 2022 Sep; 34(5):274-279. PubMed ID: 35791863
[TBL] [Abstract][Full Text] [Related]
15. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
Ibrahim H; Perl A; Smith D; Lewis T; Kon Z; Goldenberg R; Yarta K; Staniloae C; Williams M
Clin Immunol; 2020 Oct; 219():108544. PubMed ID: 32707089
[TBL] [Abstract][Full Text] [Related]
17. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.
Feldstein LR; Rose EB; Horwitz SM; Collins JP; Newhams MM; Son MBF; Newburger JW; Kleinman LC; Heidemann SM; Martin AA; Singh AR; Li S; Tarquinio KM; Jaggi P; Oster ME; Zackai SP; Gillen J; Ratner AJ; Walsh RF; Fitzgerald JC; Keenaghan MA; Alharash H; Doymaz S; Clouser KN; Giuliano JS; Gupta A; Parker RM; Maddux AB; Havalad V; Ramsingh S; Bukulmez H; Bradford TT; Smith LS; Tenforde MW; Carroll CL; Riggs BJ; Gertz SJ; Daube A; Lansell A; Coronado Munoz A; Hobbs CV; Marohn KL; Halasa NB; Patel MM; Randolph AG; ;
N Engl J Med; 2020 Jul; 383(4):334-346. PubMed ID: 32598831
[TBL] [Abstract][Full Text] [Related]
18. Xuebijing injection in the treatment of COVID-19: a retrospective case-control study.
Guo H; Zheng J; Huang G; Xiang Y; Lang C; Li B; Huang D; Sun Q; Luo Y; Zhang Y; Huang L; Fang W; Zheng Y; Wan S
Ann Palliat Med; 2020 Sep; 9(5):3235-3248. PubMed ID: 32954754
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
[TBL] [Abstract][Full Text] [Related]
20. A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases.
Mahmud-Al-Rafat A; Muzammal Haque Asim M; Taylor-Robinson AW; Majumder A; Muktadir A; Muktadir H; Karim M; Khan I; Mainul Ahasan M; Morsaline Billah M
Cytokine; 2020 Dec; 136():155228. PubMed ID: 32822911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
